August 25 - A Campaign Built on Prejudice and Paranoia; An Organizer of the "Cocks Not Glocks" Protest; Pharma Executives Price Gouge Then Reward Themselves

Share this Share this

Full Program

LISTEN TO FULL PROGRAM  

Part 1

We begin with the speech today in Reno, Nevada by Hillary Clinton who confronted Donald Trump with the charge that he has built his campaign on prejudice and paranoia, accusing him of taking “hate groups mainstream and helping a radical fringe take over the Republican Party”.  Michelle Goldberg, a senior contributing writer for Slate magazine where she has an article “How the ‘Hipster Nazis’ on the Alt-Right Got Big Enough for Hillary Clinton to Denounce Them”, joins us to discuss whether Trump’s effort to preempt the speech by calling Clinton a bigot will blunt Clinton’s factual case that Trump “is someone who’s questioned the citizenship of the first African-American president, who has courted white supremacists, who’s been sued for housing discrimination against communities of color, who’s attacked a judge for his Mexican heritage and promised a mass forced deportation, is someone who is very much peddling bigotry, prejudice and paranoia”.

Image result for Michelle Goldberg

Part 2

Then we speak with Elyse Avina, the president of Students Against Campus Carry at the University of Texas, Austin and one of the organizers of the #cocksnotglocks protest which took place yesterday on the first day of classes highlighting the absurdity of the so-called campus carry law backed by the state’s Republican leaders that allows students over 21 to carry concealed handguns into college classrooms.  

Image result for Elyse Avina

Part 3

Then finally we look into the price gouging by Mylan, the sole supplier of Epipens, a lifesaving emergency injection for people who have allergic reactions to peanuts or bee stings etc. that used to be priced at $100, but since Mylan acquired the device in 2007, the price has skyrocketed to $600 along with the salaries for Mylan’s top executives. David Howard,  a faculty member in the Department of Health Policy at Emory University and a former consultant to the Center for Medicare and Medicaid Services, joins us to discuss how Mylan’s move to increase eligibility for its patient assistant program for low-income customers is a cosmetic PR ploy that will not lower the price for the majority of patients who need Epipens.

Image result for david howard emory

 

mp3audio: